Matinas Biopharma Stock Price (NYSEMKT:MTNB)

Add to My Stocks
$0.41 $0.01 (2.38%) MTNB stock closing price Sep 19, 2018 (Closing)
Prev Close* : $0.42
Market Cap:
$39.68M
Day Low: $0.4
52 Week Low: $0.32
Open: $0.45
Volume: -
Day High: $0.45
52 Week High: $1.60
Dividend:
0.00

Latest Stock Market News

Latest Articles

Matinas Biopharma News - From Partners

MTNB Stockcharts

View MTNB PE ratio, PS ratio stocks charts and compare with peers.
MTNB Chart
Note: Compare Matinas Biopharma stock price history with the index and industry peers.

Matinas Biopharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
173.12
PB ratio (
price to book ratio
)
3.19

Matinas Biopharma Returns

ROE
(return on equity)
-122%

Matinas Biopharma Financial Ratios

Asset Turnover
0.03
Receivables Turnover
12.22
Debt to Equity
0.01
Dividend Yield
0%

MTNB Industry Peers

Company Price Change (%)
Soleno Therptcs (SLNO)2.050.02 (0.99%)
Heat Biologics (HTBX)1.870.02 (1.06%)
Tetraphase Pharmaceuticals (TTPH)3.010.11 (3.79%)
Achaogen (AKAO)4.560.28 (6.54%)
Insmed (INSM)20.310.86 (4.42%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Achaogen (AKAO)4.560.28 (6.54%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

Matinas BioPharma Holdings Inc Stock News - Partner Headlines

Matinas Biopharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-15.48M-7.59M-9.13M-10.22M-3.71M
Total Operating Expense16.65M8.24M10.1M10.45M3.71M
View Matinas Biopharma income statement
balance sheet20172016201520142013
Total Assets14.42M9.81M8.4M3.36M11.33M
Total Liabilities3.74M2.66M2.33M1.13M-
Shareholders Equity10.68M7.14M6.07M2.22M10.47M
View Matinas Biopharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities--0.09M-0.32M--
Net Cash from (used by) Operating Activities-11.45M-6.11M-7.81M-7.96M-2.98M
Increase (Decrease) in Prop Plant And Equipment-0.94M--0.07M-0.28M-0.09M
View Matinas Biopharma cash flow statement

Matinas Biopharma Stock Message Board

An investor needs to spend $0.41 to buy MTNB stock, as the closing Matinas Biopharma stock price is $0.41. The total market value as denoted by $39.68M for Matinas Biopharma, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Matinas Biopharma stock analysis.

For recognizing and analyzing the real performance of Matinas Biopharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume number in Matinas Biopharma stock quote data shows the number of shares traded. For Ex: 385,900 Matinas Biopharma shares were traded as of last trading day, as seen from Matinas Biopharma stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Matinas Biopharma dividend per share was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Matinas Biopharma stock price history.